Anke Reingen News Today

ZURICH, May 23 - Julius Baer on Thursday reported net new money of 1 billion Swiss francs in the first four months of 2024, undershooting forecasts, as...

In a research note published by Anke Reingen, RBC advises its customers to buy the stock. The target price is unchanged at CHF 28.

(Bloomberg) -- The recent selloff in UBS Group AG shares underscores the Swiss bank’s challenge to demonstrate its Credit Suisse Group AG acquisition is on solid ground.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackFrance’s Macron Calls for Reset of Economic Ties With ChinaBuffett Praises Apple After Trimming It, Drops Paramount StakeTreasury Rally Risks Running Into a $125 Billion Brick WallXi Begins Europe Tour in Paris as Macron Seeks to ...

Analyst Anke Reingen from RBC research gives the stock a Neutral rating. The target price remains set at EUR 16.50.

A year after the failure of Credit Suisse, the Swiss government says UBS may have to find as much as $27 billion to absorb potential losses. Now, the giant Swiss lender is hitting back, saying its finances are robust.

Anke Reingen from RBC retains his positive opinion on the stock with a Buy rating. The target price continues to be set at EUR 16.

The Canadian bank RBC has left its rating for Deutsche Bank at Outperform with a target price of 16 euros after the quarterly figures. Although the share price has risen significantly in recent...

Anke Reingen from RBC retains his positive opinion on the stock with a Buy rating. The target price is still set at EUR 77.

In his latest research note, analyst Anke Reingen confirms his positive recommendation. The broker RBC is keeping its Buy rating. The target price is lowered from CHF 29 to CHF 28.

Analyst Anke Reingen from RBC research gives the stock a Neutral rating. The target price has been raised to EUR 16.50 from EUR 15.50.